Search

Introduction: Circulatory assistance from a SynCardia Total Artificial Heart (SynCardia-TAH) is a reliable bridge-to-transplant solution for patients with end-stage biventricular heart failure. Ischemic strokes affect about 10% of patients with a SynCardia-TAH. We report for the first time in the literature two successful thrombectomies to treat the acute phase of ischemic stroke in two patients treated with a SynCardia-TAH in the bridge-to-transplant (BTT). Case report: We follow two patients with circulatory support from a SynCardia-TAH in the bridge-to-transplant for terminal biventricular cardiac failure with ischemic stroke during the support period. An early in-hospital diagnosis enables the completion of a mechanical thrombectomy within the first 6 h of the onset of symptoms. There was no intracranial hemorrhagic complication during or after the procedure and the patients fully recovered from neurological deficits, allowing a successful heart transplant. Conclusion: This case report describes the possibility of treating ischemic strokes under a SynCardia-TAH by mechanical thrombectomy following the same recommendations as for the general population with excellent results and without any hemorrhagic complication during or after the procedure.

OBJECTIVES At our centre, the SynCardia temporary Total Artificial Heart (TAH-t) (SynCardia Systems, LLC, Tucson, AZ, USA) is used to provide long-term support for patients with biventricular failure as a bridge to a transplant. However, a heart transplant (HT) after such support remains challenging. The aim of this retrospective study was to assess the immediate and long-term results following an HT in the cohort of patients who had a TAH-t implant. METHODS A total of 73 patients were implanted with the TAH-t between 1988 and 2019 in our centre. Of these 73 consecutive patients, 50 (68%) received an HT and are included in this retrospective analysis of prospectively collected data. RESULTS In the selected cohort, in-hospital mortality after an HT was 10% (n = 5). The median intensive care unit stay was 33 days (range 5–278). The median hospital stay was 41 days (range 28–650). A partial or total pericardiectomy was performed during the HT procedure in 21 patients (42%) due to a severe pericardial reaction. Long-term survival rates after an HT at 5, 10 and 12 years were 79.1 ± 5.9% (n = 32), 76.5 ± 6.3% (n = 22) and 72.4 ± 7.1% (n = 12), respectively, which was similar to the long-term survival for a primary HT without TAH-t during the same period (n = 686). An HT performed within 3–6 months post-TAH-t implantation appeared to provide the best survival (P = 0.007). Eight (16%) patients required chronic dialysis during the subsequent follow-up period, with 3 patients requiring a kidney transplant. CONCLUSIONS The long-term outcomes with the SynCardia TAH-t as a bridge to transplant in patients with severe biventricular failure are very encouraging. Our review noted that an HT following TAH-t can be technically challenging, especially in the case of a severe pericardial reaction, with potential pitfalls that should be recognized preoperatively.

This paper details flight results from the PI-in-a-Box project. The project is an attempt to understand the issues involved in building automated real-time advisory systems to improve the conduct of science in remote laboratory settings. This is an important problem as examples of these situations can be found throughout aerospace. A knowledge-based approach is used to facilitate real-time reactions to experiment data as it is collected by a competent, but not expert, operator. The system was flown on the Space Shuttle in October, 1993. The PI-in-a-Box system was able to outperform humans in a variety of science-related tasks. These tasks include data integrity assurance, data analysis, and scientific model validation.

Prevention of vasospasm is a challenging issue in subarachnoid hemorrhage (SAH) patients and the objective is to compare high dobutamine-induced cardiac index (CI) and high norepinephrine-induced hypertension for the prevention of vasospasm in SAH patients.Single center, single blind, controlled randomized study. Patients hospitalized in intensive care unit (ICU) for a moderate to severe SAH (WFNS grade ≥2) were randomized to receive dobutamine to reach a 25 % increase in cardiac index or norepinephrine to reach a mean arterial pressure ≥100 mmHg. Norepinephrine could be used in the dobutamine group to maintain a cerebral pressure perfusion ≥60 mmHg. Primary endpoint was the incidence of angiographic vasospasm in the first 14 days in the ICU setting, which was upheld by a cerebral arteriography. Secondary endpoints were the incidence of delayed ischemic deficits, duration of mechanical ventilation, and ICU length of stay (LOS).During the 3-year study, 41 patients were randomized. Six patients were excluded--3 because of consent withdrawal and 3 who did not receive the assigned treatment. Respectively, 17 and 18 patients in the dobutamine and the norepinephrine group were kept in analysis. Five (28 %) patients in the dobutamine group and 5 (27 %) patients in the norepinephrine group developed vasospasm in ICU (p = 1). Seven (41 %) patients presented a delayed ischemic deficit in the dobutamine group and 9 (50 %) in the norepinephrine group (p = 0.24). Duration of mechanical ventilation was 8 [0.5-11.5] days in the dobutamine group and 19 [2.7-23] days in the norepinephrine group (p = 0.01). ICU LOS was 11 [6-15] days in the dobutamine group and 21 [9-28] days in the norepinephrine group (p = 0.01).As compared to norepinephrine-induced hypertension, dobutamine-induced high CI did not reduce the rate of vasospasm in SAH patients. Dobutamine may reduce durations of mechanical ventilation and ICU LOS.

The 4 payload crew members of the Spacelab Life Sciences 9-day space flight in 1991 were subjected to limited vestibular testing in flight as well as pre and post flight. Major differences in individual "perceptual style" appeared in their reaction to the visual-vestibular stimuli in the rotating dome experiment, and especially in the extent to which nondirectional tactile cues served to anchor the subjective vertical and body postural reactions. The ability of subjects to point to remembered target positions was degraded in space, which produced a tendency to point low in some subjects in flight. The eye movements and subjective response to sudden stops and head pitching following continuous spinning (dumping) were measured both in space and on the ground. Although subjective duration of inflight rotation for the dumping tests was shorter than that for the preflight tests, the postrotatory nystagmus, with or without head pitch, was lengthened in time constant relative to preflight. Ground tests, in addition to the flight experiments, investigated the changes following weightlessness in subjective and oculomotor reactions to whole body tilt, the ability to balance with eyes open and closed; leg muscles strength and stamina as related to posture; visual field dependence; and the perceptual and oculomotor reactions to horizontal linear acceleration. Several of these tests, as well as post-flight measures of motion sickness susceptibility, revealed subtle evidence of neurovestibular alterations that lasted a week or more following the 10-day orbital exposure.

NASA's space science program suffers under operational constraints that severely limit scientific reactivity. We describe a possible extension to an existing system that enables space science to be conducted in a more reactive manner through advanced automation techniques that have recently been used in the Space Transportation System (STS)-based Spacelab. This automation allows sophisticated autonomous control of the experiment by monitoring and dynamically controlling the progress of the experiment protocol. This new approach permits intelligent conduct of experimental research investigations whether or not the crew is available or contact with the ground is possible. We describe an intelligent software assistant that can manage the conduct of the experiment autonomously, by providing responsive telepresence science, or by assisting the astronaut operator with scientific advice. The crew could be unavailable for short periods when the experiment has low priority, or for longer periods on partially tended Space Station. We suggest this system could be developed as a ground prototype using commercial hardware, versions of which have been flight qualified, in order to provide a natural transition path towards flight use. In order to make this demonstration most valuable, we propose not to select a particular Life Sciences experiment, but to include an experiment simulator representative of major scientific domains.